Single-Institution Comparative Study of Magnetic Resonance-Guided Laser Interstitial Thermal Therapy and Open Corpus Callosotomy.

World Neurosurg

Division of Pediatric Neurosurgery, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Electronic address:

Published: July 2023

Objective: Open corpus callosotomy (CC) poses a higher risk of perioperative morbidity than does magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) for treatment of drop and generalized seizures without documented superiority. We present a single-institution comparison between open and MRgLITT CC.

Methods: A 2-year retrospective review was performed of patients who underwent open and MRgLITT CC (January 2019-January 2021). Demographics, surgical outcome data, hospital costs, and interhemispheric connectivity with diffusion tensor imaging were compared.

Results: The average age in years was 9.3 and 11.4 for CC (n = 4) and MRgLITT (n = 9), respectively. Preoperative drop seizure frequency was higher in CC (25 vs. 14.5 seizures/day; P = 0.59). At 10 months follow-up, the reduction in drop seizure frequency was better in open CC, but not statistically significant (93.8% vs. 64.3%; P = 0.21). The extent of CC ablation did not correlate with seizure reduction (Pearson coefficient = 0.09). An inverse correlation between interhemispheric connectivity change (diffusion tensor imaging analysis) and drop seizure frequency reduction was noted (Pearson coefficient = -0.97). Total hospital cost was significantly lower in MRgLITT ($67,754 vs. $107,111; P = 0.004), attributed to lower intensive care unit (1.1 vs. 4 days; P= 0.004) and total hospital stay (1.8 vs. 10.5 days; P = 0.0001). Postoperative hydrocephalus was present in 75% of patients in the CC group compared with zero in the MRgLITT group.

Conclusions: Our middle-volume single-institution experience shows the safety, efficacy, and cost-effective benefit of MRgLITT compared with the traditional CC with therapeutic equipoise. This study is limited by the number of patients and, hence, further patient enrollment or multicenter study is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2023.03.082DOI Listing

Publication Analysis

Top Keywords

drop seizure
12
seizure frequency
12
magnetic resonance-guided
8
resonance-guided laser
8
laser interstitial
8
interstitial thermal
8
thermal therapy
8
open corpus
8
corpus callosotomy
8
open mrglitt
8

Similar Publications

Introduction: The seizures in Lennox-Gastaut syndrome are typically resistant to treatment. Seven antiseizure medications (ASMs) in the US (six in the UK/EU) are licensed for the treatment of seizures in LGS: lamotrigine, topiramate, rufinamide, clobazam, felbamate (not licensed in the UK/EU), cannabidiol and fenfluramine. Other options include neurostimulation, corpus callosotomy and dietary therapies, principally the ketogenic diet and its variants.

View Article and Find Full Text PDF

Early Neuro-Deterioration and Mortality Among Neurology Inpatients in a Zambian Referral Hospital: A Prospective Cohort Study.

Neurology

January 2025

From the Department of Neurology (M.L.P.), Yale School of Medicine, New Haven, CT; University Teaching Hospital (K.K., M.K.), Lusaka, Zambia; Department of Neurology (V.S.), University of Maryland School of Medicine, Baltimore, MD; Department of Medicine (K.M., M.B., M. Chilando, M.L., D.N., D.M., C.N., J.M., F.S., L.Y., M.A., S.B., L.C., M. Chomba, S.Z., N.M., D.R.S.), University of Zambia School of Medicine, Lusaka; University of Miami School of Medicine (G.P., H.P.), FL; Queen's University (A.P.), Kingston, Ontario, Canada; and Department of Neurology (D.R.S.), Johns Hopkins University School of Medicine, Baltimore, MD.

Article Synopsis
  • Neurocritical illnesses often lead to increased mortality in low-resource countries, and early neurodeterioration (END) may help identify high-risk patients for better care.
  • A study conducted in Zambia monitored neurology inpatients to assess the impact of END, defined as a decline in the Glasgow Coma Scale (GCS) within three days of admission.
  • The results showed that 18% of patients experienced END, significantly increasing their risk of death (72% vs 11% mortality), with common causes of death being aspiration pneumonia and sepsis, indicating a need for targeted interventions.
View Article and Find Full Text PDF
Article Synopsis
  • * A 17-year-old male presented with headaches and walking difficulties, leading to the discovery of a CPA lesion, which was surgically removed and diagnosed as medulloblastoma; he then received chemo-radiotherapy.
  • * After two years, the patient experienced new headaches and seizures, resulting in the identification of a metastatic tumor in the temporal lobe, also confirmed as medulloblastoma.
View Article and Find Full Text PDF

Objectives: The Phase 3 Study 338 (NCT02834793) assessed long-term clinical outcomes of adjunctive perampanel in patients ≥2 years of age with uncontrolled seizures associated with Lennox-Gastaut syndrome (LGS).

Methods: Eligible patients were diagnosed with LGS and receiving one to four concomitant antiseizure medications with an average of two or more drop seizures/week during baseline. The study comprised an 18-week double-blind, randomized, placebo-controlled Core Study and ≥52-week open-label Extension.

View Article and Find Full Text PDF

A 43-year-old man was admitted into the emergency room at our hospital after presenting with a tonic-clonic seizure. MRI showed a right-side operculo-insular tumor. This was treated by performing a craniotomy under general anesthesia with intraoperative monitoring.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!